Recombinant Fibrinogen

Patent No. EP2310411 (titled "Recombinant Fibrinogen") was filed by Profibrix on Jul 9, 2009. The application was issued on Mar 20, 2019.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
OLSWANG LLPFeb 10, 2017STEPHEN

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2310411

PROFIBRIX
Application Number
EP09793957A
Filing Date
Jul 9, 2009
Status
Patent Maintained As Amended
Feb 15, 2019
Publication Date
Mar 20, 2019